A limited supply of cannabis in the U.S. means those resources have to be divvied up carefully. For Cronos Group, that means keeping its medical and recreational marijuana operations in completely different verticals, CEO Michael Gorenstein told Cheddar. That ensures patients’ needs are prioritized over those of recreational users. “If you think about building a town, and you have a limited amount of building supplies, we want to make sure that we’re building a hospital before we’re building the bar,” he said. Canada-based Cronos Group started trading on the NASDAQ on Tuesday, making it the first marijuana company to list on a major U.S. market. “It’s a big milestone not just for us but for the entire industry,” said Gorenstein. “[It] just continues to show the acceptance that the cannabis industry is getting.” And the industry does seem to be growing at break-neck speed. Arcview, a leading researcher of the cannabis market, stated in a [recent report](https://arcviewgroup.com/product/5th-edition/) that the industry brought in $9.7 billion in sales in 2017, and that number could grow to over $25 billion by 2021. For the full interview, [click here](https://cheddar.com/videos/inside-the-first-cannabis-company-to-list-on-nasdaq).

Share:
More In Business
Keeping Employees Safe in Extreme Heat
UPS recently announced it would equip delivery trucks with air conditioning. Dr. Douglas Casa, CEO of Korey Stringer Institute at the University of Connecticut, spoke with Cheddar News on the dangers of heat stroke and how workers can keep themselves safe from extreme weather.
Stretching Your Dollar: How to Make Home EV Charging Affordable
The push for clean energy is igniting an interest in electric vehicles but charging EVs continues to be a concern for consumers looking to save. Brian Moody, executive editor with Autotrader, joined Cheddar News to discuss how people can make home-charging more affordable.
Load More